These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8719303

  • 1. GH responsiveness to repeated GHRH or hexarelin administration in normal adults.
    Sartorio A, Conti A, Ferrero S, Spada A, Faglia G.
    J Endocrinol Invest; 1995 Oct; 18(9):718-22. PubMed ID: 8719303
    [Abstract] [Full Text] [Related]

  • 2. Galanin infusion partially restores the blunted growth hormone responses to repeated growth hormone releasing hormone stimuli in normal adults.
    Sartorio A, Spada A, Conti A, Grugni G, Morabito F, Faglia G.
    J Endocrinol Invest; 1993 Feb; 16(2):95-8. PubMed ID: 7681861
    [Abstract] [Full Text] [Related]

  • 3. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
    Massoud AF, Hindmarsh PC, Matthews DR, Brook CG.
    Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
    [Abstract] [Full Text] [Related]

  • 4. Different GH responsiveness to repeated GHRH administration in normal children and adults.
    Sartorio A, Spada A, Morabito F, Faglia G.
    J Endocrinol Invest; 1988 Nov; 11(10):727-9. PubMed ID: 3148001
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hexarelin induced growth hormone release is influenced by exogenous growth hormone.
    Massoud AF, Hindmarsh PC, Brook CG.
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):617-21. PubMed ID: 8548947
    [Abstract] [Full Text] [Related]

  • 11. Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man.
    Arvat E, Maccagno B, Ramunni J, Gianotti L, Di Vito L, Deghenghi R, Camanni F, Ghigo E.
    J Endocrinol Invest; 1997 Mar; 20(3):122-7. PubMed ID: 9186817
    [Abstract] [Full Text] [Related]

  • 12. Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study.
    Massoud AF, Hindmarsh PC, Brook CG.
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4338-41. PubMed ID: 8954038
    [Abstract] [Full Text] [Related]

  • 13. Six-week treatment with hexarelin in young dogs: evaluation of the GH responsiveness to acute hexarelin or GHRH administration, and of the orexigenic effect of hexarelin.
    Rigamonti AE, Cella SG, Marazzi N, Müller EE.
    Eur J Endocrinol; 1999 Sep; 141(3):313-20. PubMed ID: 10474131
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.
    Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F.
    J Clin Endocrinol Metab; 1994 Mar; 78(3):693-8. PubMed ID: 8126144
    [Abstract] [Full Text] [Related]

  • 15. Hypothalamic control of growth hormone (GH) secretion in type I diabetic men: effect of the combined administration of GH-releasing hormone and hexarelin, a novel GHRP-6 analog.
    Giustina A, Desenzani P, Perini P, Deghenghi R, Bugari G, Wehrenberg WB, Giustina G.
    Endocr Res; 1996 May; 22(2):159-74. PubMed ID: 8799695
    [Abstract] [Full Text] [Related]

  • 16. Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone.
    Giustina A, Bonfanti C, Licini M, Ragni G, Stefana B.
    Regul Pept; 1997 May 14; 70(1):49-54. PubMed ID: 9250581
    [Abstract] [Full Text] [Related]

  • 17. Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function.
    Torsello A, Luoni M, Grilli R, Guidi M, Wehrenberg WB, Deghenghi R, Müller EE, Locatelli V.
    Neuroendocrinology; 1997 Feb 14; 65(2):91-7. PubMed ID: 9067986
    [Abstract] [Full Text] [Related]

  • 18. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E, Gianotti L, Arvat E, Ramunni J, Valetto MR, Broglio F, Rolla M, Cavagnini F, Müller EE.
    J Clin Endocrinol Metab; 1999 Jan 14; 84(1):285-90. PubMed ID: 9920097
    [Abstract] [Full Text] [Related]

  • 19. Galanin infusion restores the blunted GH responses to GHRH administration during GH treatment in children with constitutional growth delay.
    Sartorio A, Conti A, Monzani M, Faglia G.
    J Endocrinol Invest; 1995 Feb 14; 18(2):109-12. PubMed ID: 7543124
    [Abstract] [Full Text] [Related]

  • 20. Effects of propranolol on GH responsiveness to repeated GH-releasing hormone stimulations in normal subjects.
    Arosio M, Losa M, Bazzoni N, Bochicchio D, Palmieri E, Nava C, Faglia G.
    Acta Endocrinol (Copenh); 1990 Jun 14; 122(6):735-9. PubMed ID: 2115711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.